Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
3.650
0.00 (0.00%)
At close: Jul 6, 2026, 4:00 PM EDT
3.537
-0.113 (-3.08%)
After-hours: Jul 6, 2026, 7:24 PM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $560.14 million as of July 6, 2026. Its market cap has increased by 184.73% in one year.
Market Cap
560.14M
Enterprise Value
453.78M
1-Year Change
184.73%
Ranking
Category
Stock Price
$3.65
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $620.67M to $560.14M, a decrease of -9.75%. That is a compound annual growth rate of -0.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 560.14M | 179.90% |
| Dec 31, 2025 | 200.12M | 90.89% |
| Dec 31, 2024 | 104.84M | -87.33% |
| Dec 29, 2023 | 827.35M | 38.68% |
| Dec 30, 2022 | 596.59M | -66.78% |
| Dec 31, 2021 | 1.80B | -58.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faeth Therapeutics | 590.85M |
| MiMedx Group | 588.34M |
| Crescent Biopharma | 567.88M |
| Contineum Therapeutics | 564.53M |
| Neurogene | 558.44M |
| Assembly Biosciences | 549.73M |
| Arvinas | 541.33M |
| Shattuck Labs | 540.60M |